-
1دورية أكاديمية
المؤلفون: Ryosuke Ogata, Hiroshi Soda, Yasuhiro Tanaka, Hiroaki Senju, Midori Shimada, Koki Yamashita, Shota Nakashima, Asuka Umemura, Masataka Yoshida, Takuya Hara, Saeko Jinnai, Keisuke Iwasaki, Yuichi Fukuda, Hiroyuki Yamaguchi, Hiroshi Mukae
المصدر: Thoracic Cancer, Vol 13, Iss 1, Pp 133-136 (2022)
مصطلحات موضوعية: Epstein–Barr virus, immune cells, lymphoma, silicosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Koki Yamashita, Yuichi Fukuda, Saeko Jinnai, Midori Shimada, Ryosuke Ogata, Masataka Yoshida, Yasuhiro Tanaka, Takuya Hara, Hiroshi Mukae, Hiroaki Senju, Keisuke Iwasaki, Hiroshi Soda, Shota Nakashima, Hiroyuki Yamaguchi, Asuka Umemura
المصدر: Thoracic Cancer, Vol 13, Iss 1, Pp 133-136 (2022)
Thoracic Cancerمصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pathology, medicine.medical_specialty, Case Report, Inflammation, lymphoma, Case Reports, medicine.disease_cause, Virus, Epstein–Barr virus, Immune system, immune cells, Silicosis, immune system diseases, silicosis, hemic and lymphatic diseases, medicine, RC254-282, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Epstein-Barr Virus Positive, General Medicine, medicine.disease, Lymphoma, Oncology, medicine.symptom, business, Diffuse large B-cell lymphoma
-
3
المؤلفون: Daiki Ogawara, Hiroyuki Yamaguchi, Saeko Jinnai, Hiroshi Soda, Hirokazu Taniguchi, Takatomo Funayama, Keisuke Iwasaki, Hiromi Tomono, Masataka Yoshida, Asuka Umemura, Takuya Hara, Yuichi Fukuda, Daisuke Okuno, Hiroshi Mukae, Tatsuhiko Harada
المصدر: Thoracic Cancer. 9:1305-1311
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, General Medicine, Immunotherapy, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Immune system, 030220 oncology & carcinogenesis, Internal medicine, medicine, Cytotoxic T cell, Immunohistochemistry, Nivolumab, business, Lung cancer, Progressive disease